Crystal structure of bis[(μ2-4⋯O,O′:O′)-(4-hydroxybenzoato-κ2
 O,O′)-(1,10-phenanthroline-κ2
 N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ3
 O,O′:O′;κ3
 O,O′:O′-bis-[(4-hydroxybenzoato-κ2
 O,O′)bis(1,10-phenanthroline-κ2
 N,<

C 68 H 54 N 4 O 9 P b 2 ${\mathrm{C}}_{68}{\mathrm{H}}_{54}{\mathrm{N}}_{4}{\mathrm{O}}_{9}{\mathrm{P}\mathrm{b}}_{2}$ , monoclinic, C2/c (no. 15), a = 15.7286(14) Å, b = 16.3623(14) Å, c = 22.500(2) Å, β = 97.369 ( 1 ) ° $97.369\left(1\right)^{\circ} $ , V = 5742.7(9) Å 3 ${\mathrm{\AA}}^{3}$ , Z = 4, R g t ${R}_{gt}$ (F) = 0.0203, w R r e f ${R}_{ref}$ ( F 2 ${F}^{2}$ ) = 0.0488, T = 296(2) K.

show abstract

The crystal structure of di-μ-1-naphthylacetato-κ ³ O,O′:O;κ ³ O:O,O′-bis[(1-naphthylacetato-κ ² O,O′)(2,2′-bipyridine-κ ² N,N′)lead(II)] monohydrate, C₆₈H₅₄N₄O₉Pb₂

Deng

Hou

et al. 2023

Zeitschrift Für Kristallographie - New Crystal Structures

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Crystal structure of bis[(μ₂-4⋯O,O′:O′)-(4-hydroxybenzoato-κ² O,O′)-(1,10-phenanthroline-κ² N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ³ O,O′:O′;κ³ O,O′:O′-bis-[(4-hydroxybenzoato-κ² O,O′)bis(1,10-phenanthroline-κ² N,<

Abstract: C52H36N4O12Pb2 ⋅ H2O, monoclinic, P21/n (no. 19), a = 13.7767(1) Å, b = 7.9925(1) Å, c = 21.2490(2) Å, β = 93.1490(10)°, V = 2336.20(4) Å3, Z = 4, Rgt(F) = 0.0220, wRref(F2) = 0.0582, T = 170 K.

Cited by 1 publication

References 9 publications

The crystal structure of di-μ-1-naphthylacetato-κ ³ O,O′:O;κ ³ O:O,O′-bis[(1-naphthylacetato-κ ² O,O′)(2,2′-bipyridine-κ ² N,N′)lead(II)] monohydrate, C₆₈H₅₄N₄O₉Pb₂

The crystal structure of di-μ-1-naphthylacetato-κ ³ O,O′:O;κ ³ O:O,O′-bis[(1-naphthylacetato-κ ² O,O′)(2,2′-bipyridine-κ ² N,N′)lead(II)] monohydrate, C₆₈H₅₄N₄O₉Pb₂

Contact Info

Product

Resources

About

Crystal structure of bis[(μ2-4⋯O,O′:O′)-(4-hydroxybenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ3 O,O′:O′;κ3 O,O′:O′-bis-[(4-hydroxybenzoato-κ2 O,O′)bis(1,10-phenanthroline-κ2 N,<

Abstract: C52H36N4O12Pb2 ⋅ H2O, monoclinic, P21/n (no. 19), a = 13.7767(1) Å, b = 7.9925(1) Å, c = 21.2490(2) Å, β = 93.1490(10)°, V = 2336.20(4) Å3, Z = 4, Rgt(F) = 0.0220, wRref(F2) = 0.0582, T = 170 K.

Cited by 1 publication

References 9 publications

The crystal structure of di-μ-1-naphthylacetato-κ 3 O,O′:O;κ 3 O:O,O′-bis[(1-naphthylacetato-κ 2 O,O′)(2,2′-bipyridine-κ 2 N,N′)lead(II)] monohydrate, C68H54N4O9Pb2

The crystal structure of di-μ-1-naphthylacetato-κ 3 O,O′:O;κ 3 O:O,O′-bis[(1-naphthylacetato-κ 2 O,O′)(2,2′-bipyridine-κ 2 N,N′)lead(II)] monohydrate, C68H54N4O9Pb2

Contact Info

Product

Resources

About

Crystal structure of bis[(μ₂-4⋯O,O′:O′)-(4-hydroxybenzoato-κ² O,O′)-(1,10-phenanthroline-κ² N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ³ O,O′:O′;κ³ O,O′:O′-bis-[(4-hydroxybenzoato-κ² O,O′)bis(1,10-phenanthroline-κ² N,<

The crystal structure of di-μ-1-naphthylacetato-κ ³ O,O′:O;κ ³ O:O,O′-bis[(1-naphthylacetato-κ ² O,O′)(2,2′-bipyridine-κ ² N,N′)lead(II)] monohydrate, C₆₈H₅₄N₄O₉Pb₂

The crystal structure of di-μ-1-naphthylacetato-κ ³ O,O′:O;κ ³ O:O,O′-bis[(1-naphthylacetato-κ ² O,O′)(2,2′-bipyridine-κ ² N,N′)lead(II)] monohydrate, C₆₈H₅₄N₄O₉Pb₂